Eye cancer

You are here: 

Follow-up after treatment for eye cancer

Eye cancer behaves differently in each person, and a standard follow-up schedule would not work for everyone. People with eye cancer should talk to their doctor about a follow-up plan that suits their individual situation. Follow-up care is often shared among the cancer specialists (oncologists), the family doctor and eye specialists.

After treatment has ended, new symptoms and symptoms that don’t go away should be reported to the doctor without waiting for the next scheduled appointment. These may include:

  • change or loss of vision
  • eye pain


Follow-up after eye cancer treatment varies. Follow-up after treatment is tailored to the individual. Follow-up visits are usually scheduled:

  • every 3–6 months after initial treatment
  • if no further changes are seen, then every 6 months


During a follow-up visit, the doctor usually asks questions about the side effects of treatment and how the person is coping. The doctor will also ask people who have an artificial eye (prosthesis) if they are having any problems with it. The doctor may do a complete physical examination, including:

  • an eye examination and vision test

Tests may be ordered as part of follow-up or if the doctor suspects the cancer has come back (has recurred).

  • blood chemistry test to check liver function
  • ultrasound of the liver if liver function tests suggest liver metastasis
  • computed tomography (CT) scan
  • magnetic resonance imaging (MRI)
  • chest x-ray to check for metastasis in the lung

If a recurrence is found during follow-up, the oncology team will assess the person with cancer to determine the best treatment options.

See a list of questions to ask your doctor about follow-up after treatment.


Brock Taraba Brock has been cancer free for over a decade, thanks to the support we received from the Canadian Cancer Society.

Read Brock's story

Funding lifesaving clinical trials

Illustration of science instruments

The Canadian Cancer Society is funding lifesaving clinical trials that give people with cancer access to the newest types of treatment.

Learn more